Jpmorgan Chase & CO Kempharm, Inc Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Kempharm, Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 18,665 shares of KMPH stock, worth $92,205. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,665
Previous 15,061
23.93%
Holding current value
$92,205
Previous $74,000
24.32%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding KMPH
# of Institutions
99Shares Held
16MCall Options Held
170KPut Options Held
38.5K-
Black Rock Inc. New York, NY2.7MShares$13.3 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.42MShares$12 Million0.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$9.06 Million0.0% of portfolio
-
Altium Capital Management LP New York, NY1.16MShares$5.74 Million3.06% of portfolio
-
Woodline Partners LP San Francisco, CA1.15MShares$5.67 Million0.06% of portfolio
About KEMPHARM, INC
- Ticker KMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,493,600
- Market Cap $170M
- Description
- KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...